Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-06-06
2000-12-19
Gambel, Phillip
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241301, 4241331, 4241341, 4241351, 4241411, 4241431, 4241441, 4241531, 4241721, 4241731, 4241521, 4241851, 4241921, 514 2, 514 8, 514 15, 514863, 514888, A61K 39395, A61K 3526, A61K 3817
Patent
active
061624322
ABSTRACT:
Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Such conditions include psoriasis, UV damage, e.g., photoaging, atopic dermatitis, cutaneous T cell lymphoma such as mycosis fungoides, allergic and irritant contact dermatitis, lichen planus, alopecia areata, pyoderma gangrenosum, vitiligo, ocular cicatricial pemphigoid, and urticaria.
REFERENCES:
patent: 4956281 (1990-09-01), Wallner et al.
patent: 5547853 (1996-08-01), Wallner et al.
Abraham et al. (1991) "Expression and Function of Surface Antigens on Scleroderma Fibroblasts" Arthritis and Rheumatism 34(9):1164-1172.
Abraham et al. (1990) Interactions between Lymphocytes and Dernal Fibroblasts: An in Vitro Model of Cutaneous Lymphocyte Trafficking Exp. Cell. Res. 190:118-126.
(Editors) (1990) "Adhesion Molecules in Diagnosis and Treatment of Inflammatory Diseases" The Lancet 336:1351-1352.
Altman et al. (1990) "Transfection of genes for cell surface products involved in antigen presentation-applications to the understanding of autoimmunity" Autoimmunity 7:213-220.
Baadsgaard et al. (1989) "Psoriac Epidermal Cells Demonstrate Increased Numbers and Function of Non-Langerhans Antigen-presenting Cells" J. Invest. Dermatol. 92:190-195.
Barbosa et al. (1986) "Gene Mapping and Somatic Cell Hybrid Analysis Of The Role Of Human Lymphocyte Function-Associated Antigen-3 (LFA-3) in CTL-Target Cell Interactions" J. Immunol. 136:3085-3091.
Bierer and Burakoff (1988) "T Cell Adhesion Molecules" FASEB J. 2:2584-2590.
Bierer et al. (1988) "Expression Of The T-Cell Surface Molecule CD2 And An Epitope-Loss CD2 Mutant To Define The Role Of Lymphocyte Function-Associated Antigen 3 (LFA-3) in T-Cell Activation" Proc. Natl. Acad. Sci. USA 85:1194-1198.
Bierer et al. (1989) "A Monoclonal Antibody to LFA-3, the CD2 Ligand, Specifically Immobilizes Major Histocompatibility Complex Proteins" Eur. J. Immunol. 19:661-665.
Bockenstedt et al. (1988) "The CD2 Ligand LFA-3 Activates T Cells But Depends On The Expression And Function Of The Antigen Receptor" J. Immunol. 141:1904-1911.
Bromberg et al. (1991) "Anti-CD2 Monoclonal Antibodies Alter Cell-Mediated Immunity In Vivo" Transplantation 51:219-225.
Brown et al. (1987) "T2.2 Characterization Of CD2 Epitopes By Western Blotting" in Leukocyte Typing III, A.J. McMichael (ed.) Oxford, England: Oxford University Press, 110-112.
Brown et al. (1989) "The CD2 Antigen Associates With The T-Cell Antigen Receptor CD3 Antigen Complex On The Surface Of Human T Lymphocytes" Nature 339: 551-553.
Chang et al. (1992) "T-Cell Activation Is Potentiated by Cytokines Released by Lesional Psoriatic, but Not Normal, Epidermis" Arch. Dermatol. 128:1478.
Clayton et al. (1987) "Murine and Human T11 (CD2) cDNA Sequences Suggest A Common Signal Transduction Mechanism" Eur. J. Immunol. 17: 1367-1370.
Conti and Cosimi (1990) "Effect of Monoclonal Antibodies on Primate Allograft Rejection" Crit. Rev. Immunol. 10(2): 113-130.
Cooper (1990) "Immunoregulation in the Skin" Current Problems in Dermatology 19:69-80.
Cooper (1992) "Skin-infiltrating Lymphocytes in Normal and Disordered Skin: Activation Signals and Functional Roles in Psoriasis and Mycosis Fungoides-types Cutaneous T Cell Lymphoma" J. Dermatol. 19:731-737.
Cooper et al. (1985) "Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of langerhans cell-dependent function is followed by appearance of T6-Dr+ cells that enhance epidermal alloantigen presentation" J. Immunol. 134:129-137.
Cunningham and Harris (1992) "Antibody engineering--how to be human" TIBTECH 10.
Curtis and Barnes (1992) "The Nature of Science" in Biology, 5th ed. (Worth Publishers, Inc.):14-15.
Denning et al. (1987) "Monoclonal Antibodies to CD2 and Lymphocyte Function-Associated Antigen 3 Inhibit Human Thymic Epithelial Cell-Dependent Mature Thymocyte Activation" J. Immunol. 139:2573-2578.
Denning et al. (1988) "Purified Lymphocyte Function-Associated Antigen-3 (LFA-3) Activates Human Thymocytes Via The CD2 Pathway" J. Immunol. 141:2980-2985.
Dustin et al. (1987) "Purified Lymphocyte Function-Associated Antigen 3 Binds To CD2 And Mediates T Lymphocyte Adhesion" J. Exp. Med. 165:677-692.
Dustin et al. (1987) "T Cell Activation By LFA-3 and CD2 Antibodies" FASEB J. 46: A1239 (Abstract No. 5484).
Gonzalez-Ramos et al. (1992) "APC-Targeted Immunointervention in Psoriasis: Blockade of LFA-3-CD2 and ICAM1-LFA1 Ligand Pairing Blocks Autoreactivity to Lesional Epidermis" Clinical Research 40(2):500A.
Harris and Emery (1993) "Therapeutic antibodies--the coming of age" TIBTECH 11: 42-44.
Howard et al. (1981) "A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation" J. Immunol. 126:2117-2122.
Hughes et al. (1990) "The Endothelial Cell As A Regulator Of T-Cell Function" Immunol. Rev. 117 85-102.
Hughes et al. (1990) "Endothelial Cells Augment T Cell Interleukin 2 Production by a Contact-Dependent Mechanism Involving CD2/LFA-3 Interaction" J. Exp. Med. 171:1453-1467.
Kaplan et al. (1987) "Distribution and Turnover of Langerhans Cells During Delayed Immune Responses in Human Skin" J. Exp. Med. 165:763-776.
Koyasu et al. (1990), "Role of Interaction of CD2 Molecules With Lymphocyte Function-Associated Antigen 3 In T-Cell Recognition Of Nominal Antigen" Proc. Natl. Acad. Sci. USA 87:2603-2607.
Krensky (1990) "The Human Cytolytic T Lymphocyte Response to Transplantation Antigens" Pediatric Res. 19:1231-1234.
Krensky et al. (1983) "The Functional Significance, Distribution, And Structure Of LFA-1, LFA-2, And LFA-3: Cell Surface Antigens Associated With CTL-Target Interactions" J. Immunol. 131:611-616.
Krensky et al. (1984) "Human Lymphocyte Function Associated Antigens" Surv. Immunol. Res. 3:39-44.
Larson and Springer (1990) "Structure and function leukocyte integrins" Immunol. Revs. 114:181-217.
Le et al. (1987) "Anti-LFA-3 Monoclonal Antibody Induced Interleukin 1 (IL 3) Release By Thymic Epithelial (TE) Cells and Monocytes" FASEB J. 46(3):447 Abstract 761.
Le et al. (1990) "Ligand Binding To The LFA-3 Cell Adhesion Molecule Induces IL-1 Production By Human Thymic Epithelial Cells" J. Immunol. 144:4541-4547.
Makgoba et al. (1989) "The CDA2-LFA-3 And LFA-1-ICAM Pathways: Relevance To T-Cell Recognition" Immunol. Today 10:417-422.
Martz and Gromkowski (1985) "Lymphocyte Function-Associated Antigens: Regulation of Lymphocyte Adhesions In Vitro And immunity In Vivo" Adv. Exp. Med. Biol. 184:291-310.
Matis (1990) "The molecular basis of T-cell specificity" Ann. Rev. Immunol. 8:65-82.
Meuer et al. (1989) "The Alternative Pathway of T Cell Activation: Biology, Pathophysiology, and Perspectives for Immunopharmacology" Clin. Immunol. Immunopath. 50:S133-S138.
Meuer et al. (1984) "An Alternative Pathway of T-Cell Activation: A Functional Role for the 50 kd T11 Sheep Erythrocyte Receptor Protein" Cell 36:897-906.
Meuer et al. (1984) "The human T-cell receptor" Ann. Rev. Immunol. 2:23-50.
Miller (1993) "Specific Interaction of Lymphocye Functin-associated Antigen 3 with CD2 Can Inhibit T Cell Responses" J. Exp. Med. 178:211-222.
Moingeon et al. (1991) "Complementary Roles For CD2 And LFA-1 Adhesion Pathways During T Cell Activation" Eur. J. Immunol. 21:605-610.
Moingeon et al. (1989) "The Structural Biology of CD2" Immunol. Rev. 111:111-144.
Nathan et al. (1986) "Local and Systemic Effects of Intradermal Recombinant Interferon-.gamma. in Patients with Lepromatous Leprosy" New Eng. J. Med. 315(1):6-15.
Nouri et al. (1990) "Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma" J. Br. Cancer 62:603-606.
Osband et al. (1990) "Problem in the investigational Study and Clinical Use of Cancer Immunotherapy" Immunology Today 11(6):193-195.
Pepino et al. (1989) "Primate Cardiac Allo- and Xenotransplantation: Modulation of the Immune Response with Photochemotheraphy" Eur. Surg. Res. 21:105-113.
Peterson and
Cooper Kevin D.
Wallner Barbara P.
Biogen Inc.
Gambel Phillip
The Regents of the University of Michigan
LandOfFree
Method of prophylaxis or treatment of antigen presenting cell dr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of prophylaxis or treatment of antigen presenting cell dr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prophylaxis or treatment of antigen presenting cell dr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-268931